Effect of Liposome Composition and Other Factors on the Targeting of Liposomes to Experimental Tumors: Biodistribution and Imaging Studies

Cancer Research

Volumn 50, Issue 19, 1990, Pages 6371-6378

  Gabizon, Alberto ^a,b   Price, David C ^a   Huberty, John ^a   Bresalier, Robert S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Liposome Technology Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; DEFEROXAMINE; GALLIUM 67; INDIUM 111; LIPOSOME; RADIOISOTOPE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER SCINTISCANNING; DRUG TARGETING; HUMAN; HUMAN CELL; ISOTOPE LABELING; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; BLEOMYCIN; CHEMISTRY, PHARMACEUTICAL; COLONIC NEOPLASMS; DEFEROXAMINE; DRUG CARRIERS; GALLIUM RADIOISOTOPES; HUMAN; INDIUM RADIOISOTOPES; LIPOSOMES; LIVER; MELANOMA, EXPERIMENTAL; MICE; MICE, NUDE; PHOSPHATIDYLINOSITOLS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TISSUE DISTRIBUTION;

EID: 0025162391     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Perez-Soler, R. Liposomes as carriers of antitumor agents: toward a clinical reality. Cancer Treat. Rev., 16:67–82, 1989.
2. Gabizon, A. Liposomes as a drug delivery system in cancer chemotherapy. In: F. H. Roerdink and A. M. Kroon (eds.), Drug Carrier Systems, Horizons in Biochemistry and Biophysics Series, Vol. 9, pp. 185–211. Chichester: John Wiley and Sons, 1989.
3. Poste, G. Liposome targeting in vivo: problems and opportunities. Biol. Cell, 47:19–38, 1983.
4. Weinstein, J. N. Liposomes as drug carriers in cancer chemotherapy. Cancer Treat. Rep., 68:127–135, 1984.
5. Gabizon, A., and Papahadjopoulos, D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. USA, 85:6949–6953, 1988.
6. Lichtenberg, D., and Barenholz, Y. Liposomes: preparation, characterization, and preservation. In: D. Glick (ed.), Methods in Biochemical Analysis, Vol. 33, pp. 337–462. New York: John Wiley and Sons, 1988.
7. Bartlett, G. R. Phosphorus assay in column chromatography. J. Biol. Chem., 234:466–468, 1959.
8. Bligh, E. G., and Dyer, W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol., 37:911–917, 1959.
9. Gabizon, A., Hliberty, J., Straubinger, R. M., Price, D. C., and Papahadjopoulos, D. An improved method for in vivo tracing and imaging liposomes using a 67Gallium-deferoxamine complex. J. Liposome Res., 1: 123–135, 1988.
10. Gabizon, A., and Trainin, N. Enhancement of growth of a radiation-induced lymphoma by T cells from normal mice. Br. J. Cancer, 42: 551–558, 1980.
11. Bresalier, R. S., Raper, S. E., Hujanen, E. S., and Kim, Y. S. A new animal model for human colon cancer metastases. Int. J. Cancer, 39:625–630, 1987.
12. Mclntyre, N. Hepatic function in health and disease: implications in drug carrier use. In: G. Gregoriadis, J. Senior, and G. Poste (eds.), Targeting of Drugs with Synthetic Systems, Life Sciences Series, Vol. 113, pp. 87–96. New York: Plenum Press, 1986.
13. Hwang, K. J., Padki, M. M., Chow, D. D., Essien, H. E., Lai, J. Y., and Beaumier, P. L. Uptake of small liposomes by nonreticuloendothelial tissues. Biochim. Biophys. Acta, 901:88–96, 1987.
14. Hwang, K. J. Liposome pharmacokinetics. In: M. J. Ostro (ed.), Liposomes: From Biophysics to Therapeutics, pp. 109–155. New York: Marcel Dekker, 1987.
15. Gregoriadis, G. Fate of injected liposomes: observations on entrapped solute retention, vesicle clearance, and tissue distribution in vivo. In: G Gregoriadis (ed.), Liposomes as Drug Carriers: Recent Trends and Progress, pp. 3–18. Chichester John Wiley and Sons, 1988.
16. Allen, T. M., and Chonn, A. Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett., 223:42–46, 1987.
17. Gabizon, A., Shiota, R., and Papahadjopoulos, D. Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times. J. Natl. Cancer Inst., 81:1484–1488, 1989.
18. Proffitt, R. T., Williams, L. E., Presant, C. A., Tin, G. W., Uliana, J. A., Gamble, G. C., and Baldeschwieler, J. D. Liposomal blockade of the reticuloendothelial system: improved tumor imaging with unilamellar vesicles. Science (Wash. DC), 220: 502–505, 1983.
19. Proffitt, R. T., Williams, L. E., Presant, C. A., Tin, G. W., Uliana, J. A., Gamble, G. C., and Baldeschwieler, J. D. Tumor imaging potential of liposomes loaded with In-111-NTA: biodistribution in mice. J. Nucl. Med., 24:45–51, 1983.
20. Ogihara, I., Kojima, S., and Jay, M. Tumor uptake of 67Ga-carrying liposomes. Eur. J. Nucl. Med., 11:405–411, 1986.
21. Ogihara-Umeda, I., and Kojima, S. Increased delivery of Gallium-67 to tumors using serum-stable liposomes. J. Nucl. Med., 29: 516–523, 1988.
22. Turner, A. F., Presant, C. A., Proffitt, R. T., Williams, L. E., Winsor, D. W., and Werner, J. L. In-111-labeled liposomes: dosimetry and tumor depiction. Radiology, 166: 761–765, 1988.
23. Presant, C. A., Proffitt, R. T., Turner, A. F., Williams, L. E., Winsor, D., Werner, J. L., Kennedy, P., Wiseman, C., Gala, K., McKenna, R. J., Douglas Smith, J., Bouzaglou, S. A., Callahan, R. A., Baldeschwieler, J., and Crossley, R. J. Successful imaging of human cancer with Indium-111-labeled phospholipid vesicles. Cancer (Phila.), 62:905–911, 1988.
24. Dijkstra, J., Van Galen, W. J. M., Hulstaert, C. E., Kalicharan, D., Roerdink, F. H., and Scherphof, G. L. Interaction of liposomes with Kupffer cells in vitro. Exp. Cell Res., 150: 161–176, 1984.
25. Jain, R. K., and Gerlowski, L. E. Extravascular transport in normal and tumor tissues. CRC Crit. Rev. Oncol. Hematol., 5:115–170, 1986.
26. Peterson, H. I. (ed.) Tumor Blood Circulation: Angiogenesis, Vascular Morphology, and Blood Flow of Experimental and Human Tumors. Boca Raton: CRC Press, 1979.
27. Jain, R. K. Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. J. Natl. Cancer Inst., 81:570–576, 1989.
28. Juliano, R. L., and Stamp, D. Pharmacokinetics of liposome-encapsulated anti-tumor drugs. Biochem. Pharmacol., 27: 21–27, 1978.